Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Orasure Tech Inc (OSUR) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 475,390
  • Shares Outstanding, K 55,600
  • Annual Sales, $ 119,720 K
  • Annual Income, $ 8,170 K
  • 36-Month Beta 1.55
  • Price/Sales 3.80
  • Price/Book 2.69

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.39 +1.43%
on 01/23/17
9.09 -6.38%
on 01/11/17
-0.24 (-2.74%)
since 12/23/16
3-Month
7.09 +20.03%
on 11/04/16
9.53 -10.70%
on 12/16/16
+0.68 (+8.68%)
since 10/24/16
52-Week
5.09 +67.19%
on 01/28/16
9.53 -10.70%
on 12/16/16
+2.84 (+50.09%)
since 01/22/16

Most Recent Stories

More News
ResMed (RMD) Beats Earnings and Revenue Estimates in Q2

ResMed Inc. (RMD) announced second-quarter fiscal 2017 adjusted earnings per share (EPS) of 73 cents, consistent with the prior-year quarter level.

The Top 200 IVD Companies Worldwide

Did you know?

Research Reports Coverage on Medical Supplies Stocks -- OraSure Technologies, Integra LifeSciences, Tandem Diabetes Care, and West Pharma

Stock-Callers.com shifts its attention to four Medical Instruments and Supplies equities, which are OraSure Technologies Inc. (NASDAQ: OSUR), Integra LifeSciences Holdings Corp. (NASDAQ: IART), Tandem...

Helix Selects DNA Genotek's Oragene(R) Collection Device and GenoFIND Fulfillment Services for Genetic Discovery Applications

- Oragene�Dx saliva collection kits to provide reliable DNA samples for Helix -

OraSure to Implement $18 Million Product Supply Contract From Foreign Government for HCV Elimination Program

OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, announced today that it will begin fulfilling a contract to supply a foreign government...

OraSure Technologies, Inc. (Nasdaq: OSUR) to Ring The Nasdaq Stock Market Opening Bell

What:

OraSure Technologies to Present at the 10th Annual Canaccord Genuity Medical Technology & Diagnostics Forum

OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment...

OraSure Announces 2016 Third Quarter Financial Results

OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial results for the three and nine months ended...

How These Healthcare Stocks are Faring? -- Endologix, TransEnterix, Becton, Dickinson, and OraSure Technologies

This morning Stock-Callers.com has initiated research reports on these four healthcare stocks: Endologix Inc. (NASDAQ: ELGX), TransEnterix Inc. (NYSE MKT: TRXC), Becton, Dickinson and Company (NYSE: BDX),...

OraSure Technologies Announces 2017 Annual Meeting Date

OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that its 2017 Annual Meeting of Stockholders is scheduled to be held at 10:00 a.m. EDT (7:00 a.m. PDT) on Tuesday, May 16, 2017. This will be a...

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More

Business Summary

OraSure Technologies, Inc. is the market leader for oral fluid diagnostics. The Company develops, manufactures, and markets medical devices and diagnostic products for use by insurance companies, public health agencies, clinical laboratories, physicians' offices, and workplace sites.

See More

Support & Resistance

2nd Resistance Point 8.69
1st Resistance Point 8.58
Last Price 8.53
1st Support Level 8.38
2nd Support Level 8.29

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.